Home › Funds › VOLORIDGE INVESTMENT MANAGEMENT, LLC › GILD

VOLORIDGE INVESTMENT MANAGEMENT, LLC position in GILD

GILEAD SCIENCES INC · Health Care

VOLORIDGE INVESTMENT MANAGEMENT, LLC reported holding 856,301 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$127.6M, representing 0.57% of its reported portfolio and ranking #34 among its reported holdings. VOLORIDGE INVESTMENT MANAGEMENT, LLC has disclosed GILD holdings in 7 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)856.30K sh
Reported value held$127.63M
Portfolio Weight0.57%
First reportedQ3 2023
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How VOLORIDGE INVESTMENT MANAGEMENT, LLC's GILD position evolved

VOLORIDGE INVESTMENT MANAGEMENT, LLC first disclosed a stake in GILD in Q3 2023 at 132,674 shares (US$9.9M). The position peaked in Q1 2024 at 3,510,139 shares, worth US$257.1M. Across 7 filings, VOLORIDGE INVESTMENT MANAGEMENT, LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 856,301 shares valued at US$127.6M — an increase of 296,472 shares quarter over quarter.. Notable position changes include a 32% trim in Q2 2024 (shares rose 22% over the following quarter), a 70% increase in Q2 2026 (shares rose 18% over the following quarter), a 53% increase in Q3 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 132.67K $9.94M New
Q1 2024 3.51M $257.12M New
Q2 2024 2.38M $163.40M Reduce
Q1 2025 351.62K $39.40M New
Q1 2026 329.34K $45.90M New
Q2 2026 559.83K $70.73M Add
Q3 2026 856.30K $127.63M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include BlackRock Inc (US$18.67B), Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has VOLORIDGE INVESTMENT MANAGEMENT, LLC held GILD?

VOLORIDGE INVESTMENT MANAGEMENT, LLC has disclosed GILD holdings in 7 of the last 13 reported quarters, going back to Q3 2023.

What is VOLORIDGE INVESTMENT MANAGEMENT, LLC's current position in GILD?

As of Q3 2026, VOLORIDGE INVESTMENT MANAGEMENT, LLC holds 856.30K shares of GILD (GILEAD SCIENCES INC), valued at $127.63M, representing 0.57% of its reported portfolio and ranking #34.

Has VOLORIDGE INVESTMENT MANAGEMENT, LLC been buying or selling GILD?

In the latest 13F filing (Q3 2026), VOLORIDGE INVESTMENT MANAGEMENT, LLC increased its position in GILD. The position peaked in Q1 2024 at 3.51M shares.

Which other funds hold GILD?

Other major institutional holders of GILD include BlackRock Inc, Fidelity Management & Research (FMR), Invesco Ltd, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.